Grants and Contracts Details
| Status | Finished |
|---|---|
| Effective start/end date | 4/1/07 → 9/30/14 |
Funding
- Eli Lilly and Company: $40,130.00
A Phase 3 Clinical Study to Investigate the Prevention of Relapse in Lymphoma Using Daily Enzastaurin
- Fleischman, Roger (PI)